Short answer
Beauty Health Co (SKIN) filed an 8-K current report with the SEC on October 6, 2026 reporting Item 1.02 (Termination of a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure). $0 remaining 1.25% convertible senior notes due 2026 after full repayment on September 30, 2026.
Beauty Health Co 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.02 · Termination of a Material Definitive Agreement
- $0 remaining 1.25% convertible senior notes due 2026 after full repayment on September 30, 2026
- Accrued and unpaid interest paid alongside principal, eliminating the associated debt obligation
- Indenture satisfied and discharged, releasing SkinHealth from remaining obligations except surviving provisions
- Convertible-note overhang removed, reducing future refinancing and potential equity-dilution concerns
Item 7.01 · Regulation FD Disclosure
- Notes fully retired on September 30, 2026, one day before scheduled October 1 maturity
- $103.235M principal repayment, plus $645,218.75 accrued interest
- Debt retirement removes the Notes from the company’s outstanding obligations
- $103.235M cash outflow may reduce liquidity, with no refinancing details disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Beauty Health Co 8-K filings
Get the next SKIN 8-K as it lands
Follow SKIN for push alerts, or ask the research agent what this filing means.